E-SISTEr参与者中Burch术与自体筋膜吊带术治疗压力性尿失禁的单中心长期结果
报告E-SISTEr试验中某三级医疗中心接受Burch术或筋膜吊带术治疗压力性尿失禁参与者的长期结局。中位随访15.1年,两组控尿评分与生活质量持续改善,因压力性尿失禁再手术率低,15年无再手术生存率为85.2%(95%CI 60.8-95)。
要点
- 中位随访15.1年,Burch组与吊带组控尿评分及生活质量均持续改善。
- UDI-6第3题评分电话随访者低于门诊随访者(0.3±0.6 vs 1.3±1.1,p=0.0208)。
- 15年无再手术生存率85.2%(95%CI 60.8-95),仅3例因压力性尿失禁再手术。
核心结论
- 在该特征明确的队列中,中位随访15.1年,每组压力性尿失禁相关的控尿评分与生活质量均持续改善,再手术率低。
研究设计与样本
- E-SISTEr参与者在1个三级医疗中心接受Burch术或筋膜吊带术后的长期随访研究。
- 29例符合条件,Burch组14例、吊带组15例;21例获得长期信息,分别为11例和10例。
- 中位随访15.1年(范围11.2至16.0);通过门诊访视与结构化电话访谈评估,电话访谈由不参与患者照护的第三方完成。
- 采用UDI-6、IIQ-7及视觉模拟生活质量评分问卷;失败以因压力性尿失禁再手术时间通过Kaplan-Meier曲线衡量。
主要发现
- 电话随访13例(Burch组13例、吊带组7例)的UDI-6第3题评分低于门诊随访8例(Burch组5例、吊带组3例)(均值±SD 0.3±0.6 vs 1.3±1.1,p=0.0208)。
- 两种术式的UDI-6评分相似。
- 3例因压力性尿失禁再手术,其中1例Burch术后者置入筋膜吊带;Burch组与吊带组另2例分别在11.6年和13.5年接受注射剂治疗。
- 总体Kaplan-Meier 15年无再手术生存率为85.2%(95%CI 60.8-95)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 29例符合条件者中仅21例获得长期信息,8例中1例失访、1例死亡、7例电话无法联系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We report long-term outcomes in participants in the E-SISTEr (Extended Stress Incontinence Surgical Treatment Efficacy Trial) at 1 tertiary care center who underwent a Burch or a fascial sling procedure for stress urinary incontinence. MATERIALS AND METHODS: After receiving institutional review board approval E-SISTEr participants at 1 center who underwent midterm office evaluation in 2010 were further reevaluated at longer term followup by office visits and structured telephone interviews. The telephone interviews were performed by a third party not involved in patient care for those not seen in the last 2 years. Each group received validated questionnaires, including the UDI-6 (Urogenital Distress Inventory-Short Form), the IIQ-7 (Incontinence Impact Questionnaire-Short Form) and the visual analogue quality of life score questionnaire. Failure was measured by Kaplan-Meier curves using time to reoperation for stress urinary incontinence. RESULTS: Of the 29 eligible patients, including 14 treated with a Burch procedure and 15 treated with a sling procedure, 21 had long-term information available, including 11 and 10, respectively. Median followup was 15.1 years (range 11.2 to 16.0). One of the 8 patients was lost to followup, 1 died and 7 were unreachable by telephone. The UDI-6 question 3 score was lower for the 13 patients followed by telephone, including 13 and 7 with a Burch and a sling procedure compared to the 8 seen in clinic, including 5 and 3 with a Burch and a sling procedure, respectively (mean ± SD score 0.3 ± 0.6 vs 1.3 ± 1.1, p=0.0208). The UDI-6 scores were similar for the 2 procedures. Stress urinary incontinence reoperation was performed in 3 cases, including placement of a fascial sling in 1 Burch case. The other 2 cases in the Burch and sling groups received an injectable agent at 11.6 and 13.5 years, respectively. The overall Kaplan-Meier 15-year reoperation-free survival rate was 85.2% (95% CI 60.8-95). CONCLUSIONS: In this well characterized cohort with a median followup of 15.1 years there was sustained improvement in continence scores and quality of life related to stress urinary incontinence in each group and the reoperation rate was low.
引用
- Kuprasertkul A, Christie AL, Lemack GE, et al. Long-Term Results of Burch and Autologous Sling Procedures for Stress Urinary Incontinence in E-SISTEr Participants at 1 Site. J Urol. 2019. PMID: 31251716. doi:10.1097/JU.0000000000000421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。